These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52. [Comparison of diagnostic significance of bone and bone marrow scintigraphy in patients with Hodgkin disease]. Kanaev SV, Novikov SN, Zhukova LA, Pozharisskiĭ KM, Leenman EE, Gershanovich ML, Tiutin LA, Shelkoplias EN. Vopr Onkol; 2000 May; 46(6):676-81. PubMed ID: 11219937 [Abstract] [Full Text] [Related]
53. Focal MIBI uptake is a better indicator of active myeloma than diffuse uptake. Nandurkar D, Kalff V, Turlakow A, Spencer A, Bailey MJ, Kelly MJ. Eur J Haematol; 2006 Feb; 76(2):141-6. PubMed ID: 16405435 [Abstract] [Full Text] [Related]
54. Bone biopsy in haematological disorders. Burkhardt R, Frisch B, Bartl R. J Clin Pathol; 1982 Mar; 35(3):257-84. PubMed ID: 7040489 [Abstract] [Full Text] [Related]
57. Imaging findings and clinical features of patients with multiple myeloma with the prognostic effect of bone marrow focal and diffuse infiltration patterns on spine MRI. Aribas BK, Arda K, Yologlu Z, Ciledag N, Aktas E, Ozdemir S, Dogan K, Fen T, Dagli M. Minerva Med; 2011 Apr; 102(2):115-24. PubMed ID: 21483398 [Abstract] [Full Text] [Related]
60. Tc-99m methoxyisobutylisonitrile bone marrow imaging for predicting the levels of myeloma cells in bone marrow in multiple myeloma: correlation with CD38/CD138 expressing myeloma cells. Ak I, Aslan V, Vardareli E, Gülbaş Z. Ann Hematol; 2003 Feb; 82(2):88-92. PubMed ID: 12601486 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]